title: Neurotrophins in the ventral tegmental area: Role in social stress, mood disorders and drug abuse.
abstract: This review discusses the impact of neurotrophins and other trophic factors, including fibroblast growth factor and glial cell line-derived neurotrophic factor, on mood disorders, weight regulation and drug abuse, with an emphasis on stress- and drug-induced changes in the ventral tegmental area (VTA). Neurotrophins, comprising nerve growth factor, brain-derived neurotrophic factor (BDNF), and neurotrophins 3 and 4/5 play important roles in neuronal plasticity and the development of different psychopathologies. In the VTA, most research has focused on the role of BDNF, because other neurotrophins are not found there in significant quantities. BDNF originating in the VTA provides trophic support to dopamine neurons. The diverse intracellular signaling pathways activated by BDNF may underlie precise physiological functions specific to the VTA. In general, VTA BDNF expression increases after psychostimulant exposures, and enhanced BDNF level in the VTA facilitates psychostimulant effects. The impact of VTA BDNF on the behavioral effects of psychostimulants relies primarily on its action within the mesocorticolimbic circuit. In the case of opiates, VTA BDNF expression and effects seem to be dependent on whether an animal is drug-naïve or has a history of drug use, only the latter of which is related to dopamine mechanisms. Social defeat stress that is continuous in mice or intermittent in rats increases VTA BDNF expression, and is associated with depressive and social avoidance behaviors. Intermittent social defeat stress induces persistent VTA BDNF expression that triggers psychostimulant cross-sensitization. Understanding the cellular and molecular substrates of neurotrophin effects may lead to novel therapeutic approaches for the prevention and treatment of substance use and mood disorders.
authors.affiliation: Department of Basic Medical Sciences, University of Arizona College of Medicine, Phoenix, AZ, USA. Electronic address: nikulina@email.arizona.edu.
authors.forename: E M
authors.initials: EM
authors.lastname: Nikulina
authors.affiliation: Department of Basic Medical Sciences, University of Arizona College of Medicine, Phoenix, AZ, USA; Interdisciplinary Neuroscience Program, Arizona State University, Tempe, AZ, USA.
authors.forename: C E
authors.initials: CE
authors.lastname: Johnston
authors.affiliation: Interdisciplinary Neuroscience Program, Arizona State University, Tempe, AZ, USA.
authors.forename: J
authors.initials: J
authors.lastname: Wang
authors.affiliation: Department of Basic Medical Sciences, University of Arizona College of Medicine, Phoenix, AZ, USA; Interdisciplinary Neuroscience Program, Arizona State University, Tempe, AZ, USA; Department of Pharmacology and Department of Psychiatry, University of Arizona College of Medicine, Tucson, AZ, USA.
authors.forename: R P
authors.initials: RP
authors.lastname: Hammer
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000502:physiology*; D019208:Brain-Derived Neurotrophic Factor / Q000502:physiology*; D019964:Mood Disorders / Q000378:metabolism*; D013315:Stress, Psychological / Q000378:metabolism*; D019966:Substance-Related Disorders / Q000378:metabolism*; D017557:Ventral Tegmental Area / Q000378:metabolism*
chemical_list: D019208:Brain-Derived Neurotrophic Factor
keywords: BDNF; cross-sensitization; depression; drug abuse; social stress